ASX Announcement Results of 2026 Annual General Meeting Sydney, Australia, 6 November 2026: In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), the results of the Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) Annual General Meeting held today at...
Results of Meeting
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Recce Pharmaceuticals Ltd. has released the results of its Annual General Meeting held recently, detailing the outcomes of resolutions voted on by shareholders. All resolutions were decided by way of poll, and the announcement has been approved by the Recce Pharmaceuticals Board. Notably, a significant portion of votes against the adoption of the Remuneration Report indicates a second strike under corporate governance regulations, although a spill resolution was not passed.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Recce Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from Recce Pharmaceuticals
- AGM Presentation
- Retirement of Mr Alistair McKeough as Non-Executive Director
- Options Prospectus
- Cleansing Notice
- Application for quotation of securities - RCE
Later from Recce Pharmaceuticals
All Recce Pharmaceuticals news releasesFollow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals